Because ulcerative colitis is largely a disease of non-smokers and nicotine may have a beneficial effect on the disease, the effect of nicotine on rectal mucosa in rabbits was examined. Nicotine was given subcutaneously by an Alzet mini-pump in doses of 05, 1-25, and 2 mg/kg/day for 14 days to three groups of eight animals and compared with eight controls. Mean (SD) serum nicotine concentrations (ng/ml) were 3-5 (1.1), 8-8 (2.3), and 16-2 (5.2) respectively in the treated groups.
tions (ng/ml) were 3-5 (1.1), (2.3), and 16-2 (5.2) respectively in the treated groups. The thickness of adherent mucus on rectal mucosa in controls (median 36 rim) was significantly reduced by low dose (22 rtm, p=0-0011), and increased by high dose nicotine (48 im, p=0035). Incorporation ofradioactive glucosamine into papain resistant glycoconjugates was unchanged, indicating that mucin synthesis was unaltered. Prostaglandins (PG) were reduced, in some cases significantly (6-keto PGFia, PGF2a, and hydroxy-eicosatetraenoic acid), by nicotine, which showed an inverse dose dependence -with greatest inhibition in relation to the lowest dose. Nicotine, and possibly smoking, may affect colitis by an action on mucosal eicosanoids and on adherent surface mucus secretion in the rectum and large bowel. (Gut 1994; 35: 247-251) Ulcerative colitis is predominantly a disease of current non-smokers,' many of whom are exsmokers who develop their colitis after stopping smoking.2 Anecdotal reports suggest an improvement in colitis when some patients start smoking again.3 Nicotine may be the active agent responsible for this improvement and a pilot study of transdermal nicotine administration in patients with active disease seemed to show benefit. 6 Mucus in the colon forms a continuous adherent layer on the epithelium, acting as a barrier between the mucosal epithelial cells and the luminal contents. Since ulcerative colitis is a mucosal disease, damage by luminal contents may play a role. Factors responsible for maintaining the mucus barrier may therefore be pertinent to the pathogenesis of colitis. These include synthesis and secretion of mucin,7 thickness of the adherent surface layer,8 9 and activity of luminal proteases which are responsible for digestion of the mucus gel barrier.'0 Mucosal eicosanoids may also be relevant since, by analogy with the stomach, they probably stimulate mucin synthesis and secretion. " 12 Elucidation of the mechanisms involved in the relationship between smoking and colitis may lead to therapeutic advances. We have therefore examined the effect of nicotine on colonic mucus and mucosal eicosanoids in an animal model.
Methods

ANIMALS
The rabbit model was chosen because the eicosanoid profile for colonic mucosa is similar to that in man, and preliminary studies in mice failed to produce adequate plasma nicotine concentrations. Altogether 100 >t were injected onto two combined Nucleosil 5C18 HPLC columns (3x20 mm, Chrompack, The Netherlands). HPLC was performed with a Hewlett-Packard 1084B liquid chromatograph with dual pumping system. Radioactivity was measured on-line with a Berthold LB506C monitor. The solvent system contained a gradient of 0-12% tri-fluoroacetic acid and 0 2% triethylamine in water (pH 3 0) and acetonitril (Lichrosolv, Merck, Germany). The flow rate was 0-5 ml/min at 37°C. Picofluor (Packard Canberra, USA) was used as a premixed scintillator at a flow rate of 2-25 ml/min.2"'2 FAECAL PROTEINASE ACTIVITY Faecal samples from the rectum and caecum were stored at -70°C before processing. Samples were thawed to room temperature, suspended in 67 mmol/l sodium phosphate buffer, pH 7-5 containing 50 mmol/l sodium chloride, and centrifuged at 18 000 gfor 45 minutes at 4°C. The supernatant was retained as a faecal extract. Proteolytic activity was measured by assay of new N-terminals formed on hydrolysis of peptide bonds. 0 All samples were compared with zero incubation time controls. Proteolytic activity was expressed as mmol-N-terminals/ min/g faeces.
HISTOLOGY
Tissue samples from the caecum and rectum were fixed in buffered formalin. Paraffin embedded sections (5 [t) were stained by haematoxylin and eosin, Alcian blue (pH 2-5)-periodic acid Schiff (PAS), and the high iron diamine (HID)-alcian blue techniques.23 The latter two methods allow identification of neutral mucus glycoproteins (PAS posivite), non-sulphated sialomucins (Alcian blue positive), and sulphated sialomucins (HID positive). All samples were assessed histologically for morphological changes, inflammation, and alterations in mucus glycoprotein histochemistry, without knowledge of the treatment group.
STATISTICS
Each outcome measurement was compared between the four groups using the KruskalWallis non-parametric one-way analysis of variance; when this was significant, differences from the control group were assessed by MannWhitney U tests. The change in serum nicotine concentrations from days 6 to 14 was assessed by the paired t test.
Results
The mean (SD) concentrations of serum nicotine (ng/ml) from two measurements on days 6 and 14 were 0 4 (0-2); 3-5 (I1 1); (2-3); and 16-2 (5 -2) in the control and three nicotine groups respectively (Table I) . Compared with day 6, values on day 14 had fallen by between 12 and 36%, and the difference reached significance in the medium dose nicotine group (p=0-026, 95% confidence interval (CI) 0 5, 7 02). When animals were killed, an unexpected observation on opening the colon was that those given nicotine had softer stools than controls, and the change was most striking in the high dose group.
The thickness of the adherent mucus in the rectum differed highly significantly between the four groups (Kruskal-Wallis, p<0-001): it was reduced (p=0-001 1) with low dose and increased (p=0035) with high dose nicotine (Table II) . There was a steady progress of mucus thickness from low dose to high dose, with no overlap between the values recorded for these extreme doses (Fig 1; p<0 0002 ). There was a significant correlation between mean serum nicotine values in each animal given nicotine and the corresponding thickness of rectal mucus, r=0-71, p<0001 (Fig 2) . No significant change was found in the rate of synthesis of papain resistant glycoconjugates by rectal biopsy specimens in tissue culture (Table II) . 
